Compass Therapeutics, Inc. (CMPX)
(Delayed Data from NSDQ)
$1.00 USD
-0.20 (-16.67%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $1.10 +0.10 (10.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.10 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | 27.27% |
ABR | 1.43 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.39 |
Next Year | -0.43 |
EPS (TTM) | -0.36 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 18.65M |
# of Estimates | NA | NA | NA | 2 |
High Estimate | NA | NA | NA | 25.00M |
Low Estimate | NA | NA | NA | 12.30M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.10 | -0.10 | -0.39 | -0.43 |
# of Estimates | 6 | 6 | 7 | 7 |
Most Recent Consensus | -0.10 | -0.11 | -0.41 | -0.35 |
High Estimate | -0.08 | -0.09 | -0.36 | -0.26 |
Low Estimate | -0.11 | -0.12 | -0.43 | -0.68 |
Year ago EPS | -0.09 | -0.08 | -0.33 | -0.39 |
Year over Year Growth Est. | -11.11% | -25.00% | -18.18% | -10.99% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 6 | 5 | 7 | 6 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.10 | -0.10 | -0.39 | -0.43 |
7 Days Ago | -0.10 | -0.10 | -0.39 | -0.43 |
30 Days Ago | -0.10 | -0.10 | -0.41 | -0.45 |
60 Days Ago | -0.12 | -0.12 | -0.48 | -0.50 |
90 Days Ago | -0.12 | -0.12 | -0.48 | -0.50 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.10 | -0.10 | -0.36 | -0.26 |
Zacks Consensus Estimate | -0.10 | -0.10 | -0.39 | -0.43 |
Earnings ESP | 0.00% | 0.00% | 7.01% | 39.54% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.11 | -0.08 | -0.09 | NA |
Estimate | -0.11 | -0.09 | -0.11 | -0.08 | NA |
Difference | 0.03 | -0.02 | 0.03 | -0.01 | 0.01 |
Surprise | 27.27% | -22.22% | 27.27% | -12.50% | 4.96% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more